OracleBio is a quantitative digital pathology contract research organisation based at BioCity Scotland. The team delivers image analysis that supports translational research, clinical trials and companion diagnostic programmes, working across multiplex immunofluorescence, multiplex IHC and RNAscope assays. Scientists routinely analyse whole-slide scans produced on Akoya, Leica and Philips platforms using HALO, Visiopharm and Definiens pipelines, generating regulatory-ready reports aligned with GCP quality management.
Core strengths include:
• Study design support for multiplex biomarker panels and tissue microarrays
• Bespoke deep-learning segmentation, cell phenotyping and spatial statistics (TME, proximity, neighbourhood analysis)
• Pathologist review and quality control integrated with project management workflows
OracleBio partners with biopharma globally but keeps assay development and data science in Glasgow, enabling UK clients to access rapid turnaround support while meeting data residency requirements.